StonvexLoading…
StonvexStonvexStonvexCore line items from HXL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $531.87M | $501.50M | $1.89B | $1.40B | $946.40M |
Operating Income | Not available | $57.60M | $171.60M | $110.20M | $74.20M |
Net Income | Not available | $37.20M | $109.40M | $20.60M | $13.50M |
EPS (Diluted) | $0.59 | $0.49 | $1.37 | $0.78 | $0.52 |
Total Assets | Not available | $2.72B | $2.70B | $2.76B | $2.84B |
Total Liabilities | Not available | $1.46B | $1.45B | $1.19B | $1.29B |
Cash & Equivalents | Not available | $54.10M | $71.00M | $90.50M | $77.20M |
Free Cash Flow OCF − CapEx | Not available | $-6.20M | $157.20M | $49.90M | $-46.60M |
Shares Outstanding | Not available | 76.70M | 75.70M | 80.90M | 81.10M |